00000nam 2200000za 4500 9.847586 CaOODSP 20221107153457 cr ||||||||||| 171122s2018 onca o f000 0 eng d 9780660239637 9780660239644 CaOODSP eng n-cn--- NR16-175/2017E-PDF National Research Council Canada. Immunomodulator for asthma treatment (L-11894) [electronic resource]. [Ottawa] : National Research Council Canada, [2018] [1] p. : col. ill. Issued also in French under title: Immunomodulateur pour le traitement de l’asthme (L-11894). Caption title. "December 2017." “To address the need for a safe, disease-modifying treatment, the NRC has developed an immunomodulator that suppresses the unbalanced immune response that causes asthma”--Highlights. Issued also in print format. Immunological adjuvants Asthma Immunomodulateur pour le traitement de l’asthme (L-11894) (CaOODSP)9.847589 Immunomodulator for asthma treatment (CaOODSP)9.847588 PDF 176 KB https://publications.gc.ca/collections/collection_2018/cnrc-nrc/NR16-175-2017-eng.pdf